Invention Grant
- Patent Title: Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
-
Application No.: US15962306Application Date: 2018-04-25
-
Publication No.: US10696652B2Publication Date: 2020-06-30
- Inventor: Stephen Stokes , Nicolas Foloppe , Andrea Fiumana , Martin Drysdale , Simon Bedford , Paul Webb
- Applicant: Vernalis (R&D) Ltd.
- Applicant Address: GB Great Abington
- Assignee: Vernalis (R&D) Ltd.
- Current Assignee: Vernalis (R&D) Ltd.
- Current Assignee Address: GB Great Abington
- Agency: Banner & Witcoff, Ltd.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@57ea2bca com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@5ceb323f
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D413/14 ; A61K31/4439 ; A61K31/4545 ; A61K31/496 ; A61K31/5377
Abstract:
A method of treating a mammal suffering from a cancer responsive to inhibition of protein kinase activity, by administering to the mammal an amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, effective to inhibit protein kinase activity, wherein the compound of formula (I) is:
Public/Granted literature
- US20180244652A1 Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory Activity Public/Granted day:2018-08-30
Information query
